Keeping you informed and equipped regarding all financial matters
We have assembled a selection of information, market commentary and related links to help you gain a greater understanding of all things financial. Bookmark this page and check back for regular updates.
Weekly Market Guide
1/22/2021
Review the latest portfolio strategy commentary from Mike Gibbs, managing director of Equity Portfolio & Technical Strategy.
Markets & Investing
Will This Be Another Strong Year for Stocks?
1/21/2021
Surprisingly, U.S. equities notched strong annual growth in 2020. Will domestic and global financial markets push even higher in 2021?
Markets & Investing


2021 Outlook: A Return to Normal? [INFOGRAPHIC]
1/20/2021
Review this visual summary of the Raymond James Investment Strategy Committee’s outlook for investors in the coming year.
Markets & Investing
Have You Hired the Right Tax Accountant?
1/20/2021
Five signs you’ve chosen the right accountant; two signs that suggest proceeding with caution.
Tax Planning
So Many Variables
1/19/2021
Doug Drabik discusses fixed income market conditions and offers insight for bond investors.
Markets & Investing

The Inflation Outlook
1/15/2021
Chief Economist Scott Brown discusses current economic conditions.
Economy & Policy

Weekly Investment Strategy
1/15/2021
Review the latest Weekly Headings by CIO Larry Adam.
Markets & Investing

Weekly Market Guide
1/15/2021
Review the latest portfolio strategy commentary from Mike Gibbs, managing director of Equity Portfolio & Technical Strategy.
Markets & Investing
Weekly Market Snapshot
1/15/2021
Chief Economist Scott Brown discusses the latest market data.
Economy & Policy
Biotech Analyst Outlines COVID-19 Vaccine Progress
1/12/2021
Steve Seedhouse, Raymond James biotechnology analyst, discusses the Moderna and Pfizer vaccines’ trial results, manufacturing plans and rollout strategies.
Lifestyle & Technology
Biotech Analyst Outlines COVID-19 Vaccine Progress
1/12/2021
Steve Seedhouse, Raymond James biotechnology analyst, discusses the Moderna and Pfizer vaccines’ trial results, manufacturing plans and rollout strategies.
Lifestyle & Technology